Stereotactic Prostate Cancer Ablative Re‐Irradiation: A Systematic Review and Meta‐Analysis (SPARE)
Andre G. Gouveia,
Jody Tao,
Gregory Pond,
Kevin Dong,
Allison Ye,
Arthur A. Rosa,
Daniel M. Palhares,
Conrad J. Q. Villafuerte,
Paola Anselmo,
Fabio Y. Moraes,
Fabio Arcidiacono,
Robert Olson,
Theodoros Tsakiridis Prostate
· Wiley
· 2026-11-14
· DOI: 10.1002/pros.70233
The publisher did not provide an abstract — full text is available via the link below.
Andre G. Gouveia, Jody Tao, Gregory Pond, Kevin Dong, Allison Ye, Arthur A. Rosa et al. Stereotactic Prostate Cancer Ablative Re‐Irradiation: A Systematic Review and Meta‐Analysis (SPARE). // Prostate. – 2026. – DOI: 10.1002/pros.70233. – URL: https://onlinelibrary.wiley.com/doi/10.1002/pros.70233?af=R
Andre G. Gouveia, Jody Tao, Gregory Pond, Kevin Dong, Allison Ye, Arthur A. Rosa, Daniel M. Palhares, Conrad J. Q. Villafuerte, Paola Anselmo, Fabio Y. Moraes, Fabio Arcidiacono, Robert Olson, & Theodoros Tsakiridis (2026). Stereotactic Prostate Cancer Ablative Re‐Irradiation: A Systematic Review and Meta‐Analysis (SPARE). Prostate. https://doi.org/10.1002/pros.70233
Andre G. Gouveia, et al. “Stereotactic Prostate Cancer Ablative Re‐Irradiation: A Systematic Review and Meta‐Analysis (SPARE).” Prostate, 2026. doi:10.1002/pros.70233.
@article{Gouveia2026,
title = {Stereotactic Prostate Cancer Ablative Re‐Irradiation: A Systematic Review and Meta‐Analysis (SPARE)},
author = {Gouveia, Andre G. and Tao, Jody and Pond, Gregory and Dong, Kevin and Ye, Allison and Rosa, Arthur A. and Palhares, Daniel M. and Villafuerte, Conrad J. Q. and Anselmo, Paola and Moraes, Fabio Y. and Arcidiacono, Fabio and Olson, Robert and Tsakiridis, Theodoros},
journal = {Prostate},
year = {2026},
doi = {10.1002/pros.70233},
url = {https://onlinelibrary.wiley.com/doi/10.1002/pros.70233?af=R}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...